Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...
Short FDX slightly under 265.57, target n/a, stop loss @ 266.34 Check the time stamp on this data. Updated AI-Generated ...
The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...
We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where FedEx Corporation (NYSE:FDX) stands against the other ...
Shares of FedEx Corp. FDX slid 1.62% to $264.87 Friday, on what proved to be an all-around poor trading session for the stock ...
JPMorgan lowered the firm’s price target on UPS (UPS) to $120 from $135 and keeps a Neutral rating on the shares post the Q4 report. The ...
FedEx stock is trading lower on Thursday in sympathy with United Postal Service, which fell after it reported 2024 ...
United Parcel Service struggles with declining revenue and profit margins, with a significant stock drop due to strategic ...
Investing.com -- FedEx (NYSE: FDX) stock tumbled 3.5% today after rival United Parcel Service Inc. (NYSE: UPS) released a revenue forecast that fell short of market expectations, signaling weaker ...
In the most recent trading session, FedEx (FDX) closed at $275.06, indicating a -1.29% shift from the previous trading day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback